Skip to content

Comparative Study Matching Intraperitoneal Onlay Mesh (IPOM) and Sublay Mesh to Treat Umbilical Hernia

Prospective Randomized Multicenter Trial Comparing Laparoscopic (IPOM) vs. Sublay Mesh Plasty for Umbilical Hernia in Adults

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01201564
Enrollment
306
Registered
2010-09-14
Start date
2010-07-31
Completion date
2018-12-31
Last updated
2019-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Umbilical Hernia

Keywords

umbilical hernia,, wound complications,, mesh repair, IPOM,, quality of life,, sublay mesh repair,, recurrence rate

Brief summary

This study is designed to compare two techniques for operative care of umbilical hernia in adults regarding wound complications, wound side fluid collections, recurrence rate, postoperative pain, duration of hospitalization and quality of life. The IPOM technique provides mesh positioning directly into the abdominal cavity onto the defect under laparoscopic control while in sublay position the mesh is placed directly behind the rectus muscle after small incision close to the belly button.

Interventions

PROCEDUREintraperitoneal onlay mesh repair

The IPOM technique provides mesh positioning directly into the abdominal cavity onto the defect under laparoscopic control while in sublay position the mesh is placed directly behind des rectus muscle after small incision close to the belly button.

The IPOM technique provides mesh positioning directly into the abdominal cavity onto the defect under laparoscopic control while in sublay position the mesh is placed directly behind des rectus muscle after small incision close to the belly button.

Sponsors

Clinical Trial Unit, University Hospital Basel, Switzerland
CollaboratorOTHER
University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* informed consent * patient age: ≥ 18 years * elective surgery for umbilical hernia * hernia diameter ≥ 1cm

Exclusion criteria

* previous history of median laparotomy * navel site infection * contraindication for general anaesthesia * American Society of Anesthesiologists (ASA) score \>IV * pregnancy * cirrhosis of the liver (CHILD B and C) and/or ascites * cytostatic therapy * incarcerated hernia * recurrent hernia

Design outcomes

Primary

MeasureTime frameDescription
early wound complications30 days after operation* wound infection (with or without removal of the mesh) * wound necrosis * wound hematoma
late wound complications1 year after operation* wound infection (with or without removal of the mesh) * wound necrosis * wound hematoma

Secondary

MeasureTime frameDescription
hospital staywill be measured after discharge of the patientmeasured in days
umbilical hernia recurrence rate30 daysthe diagnosis of recurrence will be given by the surgeon clinically or due to ultrasound scan
navel site seromadischarge daythe diagnosis of seroma will be given by the surgeon clinically or by ultrasound scan and measured in ccm (height(cm) x width(cm)x length(cm))
complication rate perioperativeintraoperative complications will be recorded immediately after finishing the operation* major bleeding * bowel injury
pain score (Visual Analog Scale - VAS)24h post operativewill be measured by the nurse according to Visual Analog Scale
Quality of life (SF-36)1 day pre-operativepatients will be asked to fulfill validated SF-36 questionnaire
complication rate postoperative30 day* trocar site hernia * enteral fistula * persistent pain * re-operation
duration of operationthe duration will be recorded immediately after finishing the operationmeasured in minutes according to operations protocol (duration cut - suture)

Countries

Germany, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026